
-
Russian missile strike kills 14 in Ukraine leader's home city
-
Trump's tariff Big Bang puts global economy under threat
-
I Am Maximus backed for National as Mullins hot streak continues
-
2014 World Cup winner Hummels to retire at season's end
-
Intercommunal violence kills dozens in central Nigeria
-
Nigerian, S. African music saw 'extraordinary growth' in 2024: Spotify
-
Russell Brand: From Hollywood star to rape suspect
-
France soccer star Mbappe unveiled in London... in waxwork form
-
Trump goads China as global trade war escalates
-
Israel expands Gaza ground offensive, hits Hamas in Lebanon
-
TikTok faces new US deadline to ditch Chinese owner
-
US Fed Chair warns tariffs will likely raise inflation, cool growth
-
Mbappe among three Real Madrid players fined for 'indecent conduct'
-
How can the EU respond to Trump tariffs?
-
Canada loses jobs for first time in 3 years as US tariffs bite
-
Real Madrid and Barcelona respect each other, says Ancelotti
-
Nations divided ahead of decisive week for shipping emissions
-
Trump goads China after Beijing retaliates in global trade war
-
Arteta urges Arsenal to enjoy "beautiful" run-in despite injury woes
-
London mayor gets new powers to revive capital's ailing nightlife
-
Italy's ski star Brignone takes on 'new challenge' after serious leg injury
-
Amorim in a 'rush' to succeed at Man Utd
-
PSG coach Luis Enrique targets unbeaten season
-
Duterte victims seeking 'truth and justice': lawyer
-
US job growth strong in March but Trump tariff impact still to come
-
UK comedian and actor Russell Brand charged with rape
-
Stocks, oil slump as China retaliates and Trump digs in heels
-
Postecoglou 'falling out of love' with football due to VAR
-
EU hails 'new era' in relations with Central Asia
-
US hiring beats expectations in March as tariff uncertainty brews
-
'Unique' De Bruyne one of the greats, says Guardiola
-
Automakers shift gears after Trump tariffs
-
Where things stand in the US-China trade war
-
De Bruyne to leave Man City at end of the season
-
Youthful Matildas provide spark in friendly win over South Korea
-
Stocks, oil extend rout as China retaliates over Trump tariffs
-
De Bruyne says he will leave Man City at end of season
-
UK spy agency MI5 reveals fruity secrets in new show
-
Leverkusen's Wirtz to return 'next week', says Alonso
-
England bowler Stone to miss most of India Test series
-
Taiwan earmarks $2.7 bn to help industries hit by US tariffs
-
Rat earns world record for sniffing landmines in Cambodia
-
Elton John says new album 'freshest' since 1970s
-
EU announces 'new era' in relations with Central Asia
-
Greece nixes Acropolis shoot for 'Poor Things' director
-
'Historic moment': South Koreans react to Yoon's dismissal
-
Israel kills Hamas commander in Lebanon strike
-
Trump unveils first $5 million 'gold card' visa
-
Crashes, fires as Piastri fastest in chaotic second Japan GP practice
-
India and Bangladesh leaders meet for first time since revolution
RBGPF | 1.48% | 69.02 | $ | |
CMSC | -0.54% | 22.14 | $ | |
SCS | -1.51% | 10.58 | $ | |
NGG | -4.45% | 66.433 | $ | |
GSK | -5.89% | 36.84 | $ | |
BTI | -4.14% | 40.255 | $ | |
BP | -9.33% | 28.665 | $ | |
CMSD | -1.02% | 22.44 | $ | |
AZN | -6.81% | 69.21 | $ | |
RYCEF | -16.39% | 8.42 | $ | |
RIO | -7.15% | 54.53 | $ | |
RELX | -4.68% | 49.139 | $ | |
BCE | 1.73% | 23.06 | $ | |
BCC | 0.28% | 94.9 | $ | |
JRI | -7.1% | 11.97 | $ | |
VOD | -9.65% | 8.545 | $ |

New US strategy to make monkeypox vaccine go further
US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.
The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.
For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.
The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.
Two injections, four weeks apart, will still be necessary.
The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.
At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.
Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.
The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.
The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.
For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.
"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.
The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.
O.Karlsson--AMWN